Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,851 | 330 | 99.0% |
| Education | $58.41 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,479 | 82 | $0 (2024) |
| Novo Nordisk Inc | $1,081 | 53 | $0 (2024) |
| GlaxoSmithKline, LLC. | $525.01 | 35 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $494.82 | 20 | $0 (2024) |
| Amarin Pharma Inc. | $423.27 | 28 | $0 (2022) |
| Esperion Therapeutics, Inc. | $339.84 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $285.29 | 19 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.20 | 15 | $0 (2023) |
| PFIZER INC. | $232.68 | 17 | $0 (2023) |
| Amgen Inc. | $179.42 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.23 | 11 | GlaxoSmithKline, LLC. ($45.35) |
| 2023 | $307.93 | 16 | GlaxoSmithKline, LLC. ($97.04) |
| 2022 | $907.14 | 44 | Bayer HealthCare Pharmaceuticals Inc. ($374.82) |
| 2021 | $1,312 | 62 | AstraZeneca Pharmaceuticals LP ($342.33) |
| 2020 | $915.46 | 56 | AstraZeneca Pharmaceuticals LP ($335.91) |
| 2019 | $609.86 | 41 | AstraZeneca Pharmaceuticals LP ($187.99) |
| 2018 | $983.84 | 59 | AstraZeneca Pharmaceuticals LP ($300.50) |
| 2017 | $679.61 | 48 | AstraZeneca Pharmaceuticals LP ($192.19) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 07/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardio-renal | ||||||
| 04/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 01/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Cardio-renal | ||||||
| 01/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: RESPIRATORY | ||||||
| 12/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardio-renal | ||||||
| 12/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: DIABETES | ||||||
| 11/29/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Respiratory | ||||||
| 11/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Diabetes | ||||||
| 06/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Cardio-renal | ||||||
| 05/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Cardio-renal | ||||||
| 04/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: RESPIRATORY | ||||||
| 04/10/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,010 | 3,565 | $157,394 | $103,116 |
| 2022 | 25 | 2,180 | 3,773 | $186,912 | $119,763 |
| 2021 | 24 | 2,233 | 3,979 | $197,285 | $129,333 |
| 2020 | 27 | 2,394 | 4,341 | $206,603 | $132,671 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 626 | $84,510 | $52,044 | 61.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $16,065 | $14,962 | 93.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 37 | $8,325 | $4,862 | 58.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 56 | $5,880 | $3,506 | 59.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 35 | $4,375 | $3,296 | 75.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 23 | 33 | $4,125 | $2,950 | 71.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 129 | 138 | $6,900 | $2,949 | 42.7% |
| 83721 | Ldl cholesterol level | Office | 2023 | 144 | 278 | $3,336 | $2,861 | 85.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 160 | 594 | $2,376 | $2,328 | 98.0% |
| 84478 | Triglycerides level | Office | 2023 | 143 | 276 | $1,656 | $1,554 | 93.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,450 | $1,483 | 60.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 120 | 121 | $2,057 | $1,252 | 60.9% |
| 80076 | Liver function blood test panel | Office | 2023 | 108 | 143 | $1,859 | $1,145 | 61.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 117 | 142 | $1,846 | $1,081 | 58.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 71 | 127 | $1,905 | $1,053 | 55.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 107 | 112 | $3,024 | $1,020 | 33.7% |
| 80069 | Kidney function blood test panel | Office | 2023 | 94 | 103 | $1,442 | $876.53 | 60.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 140 | 233 | $932.00 | $794.53 | 85.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 39 | 39 | $780.00 | $690.30 | 88.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $740.00 | $654.90 | 88.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 62 | 72 | $576.00 | $439.92 | 76.4% |
| 82950 | Blood glucose (sugar) level after receiving dose of glucose | Office | 2023 | 36 | 92 | $736.00 | $427.80 | 58.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 61 | 70 | $560.00 | $355.60 | 63.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 22 | 23 | $460.00 | $301.76 | 65.6% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 26 | 34 | $204.00 | $130.90 | 64.2% |
About Dr. William Young, MD
Dr. William Young, MD is a Family Medicine healthcare provider based in Spring Hill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376649202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Young, MD has received a total of $5,910 in payments from pharmaceutical and medical device companies, with $193.23 received in 2024. These payments were reported across 337 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,851).
As a Medicare-enrolled provider, Young has provided services to 8,817 Medicare beneficiaries, totaling 15,658 services with total Medicare billing of $484,882. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Spring Hill, FL
- Active Since 09/16/2006
- Last Updated 01/17/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376649202
Products in Payments
- FARXIGA (Drug) $1,014
- Ozempic (Drug) $499.51
- Kerendia (Drug) $494.82
- TRELEGY ELLIPTA (Drug) $425.05
- Vascepa (Drug) $423.27
- BEVESPI AEROSPHERE (Drug) $269.00
- JARDIANCE (Drug) $226.82
- ELIQUIS (Drug) $215.55
- NEXLETOL (Drug) $214.84
- XARELTO (Drug) $200.75
- Victoza (Drug) $156.47
- RYBELSUS (Drug) $137.88
- Rybelsus (Drug) $130.72
- Tresiba (Drug) $129.74
- NEXLIZET (Drug) $125.00
- JANUVIA (Drug) $124.43
- EVENITY (Biological) $102.51
- BREZTRI (Drug) $95.80
- Edarbi (Drug) $95.55
- INVOKANA (Drug) $84.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Spring Hill
Dr. Howard Farrington, Md, MD
Family Medicine — Payments: $16,362
Dr. Meghan Sills, M.d, M.D
Family Medicine — Payments: $9,923
Dr. Matthew Bowser, D.o, D.O
Family Medicine — Payments: $7,923
Kristien Polecritti, D.o, D.O
Family Medicine — Payments: $6,836
Dr. Sean Cannady, Do, DO
Family Medicine — Payments: $6,091
Nathanael Lafferty, M.d, M.D
Family Medicine — Payments: $6,010